Corbin Barnes Sells 598 Shares of Innospec Inc. (NASDAQ:IOSP) Stock

Innospec Inc. (NASDAQ:IOSP) SVP Corbin Barnes sold 598 shares of the firm’s stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $103.06, for a total transaction of $61,629.88. Following the sale, the senior vice president now owns 8,051 shares in the company, valued at approximately $829,736.06. The trade was a 6.91 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Corbin Barnes also recently made the following trade(s):

• On Friday, February 21st, Corbin Barnes sold 2,692 shares of Innospec stock. The stock was sold at an average price of $103.30, for a total transaction of $278,083.60.

Innospec Price Performance

NASDAQ:IOSP opened at $104.01 on Friday. The company has a market cap of $2.60 billion, a price-to-earnings ratio of 73.25 and a beta of 1.09. Innospec Inc. has a 1 year low of $99.49 and a 1 year high of $133.71. The stock’s 50 day simple moving average is $110.29 and its two-hundred day simple moving average is $112.31.

Innospec (NASDAQ:IOSP) last announced its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.05. Innospec had a net margin of 1.93% and a return on equity of 12.27%. The company had revenue of $466.80 million for the quarter, compared to analysts’ expectations of $447.43 million. As a group, analysts anticipate that Innospec Inc. will post 6.18 EPS for the current year.

Analyst Ratings Changes

Separately, StockNews.com lowered Innospec from a “buy” rating to a “hold” rating in a research report on Wednesday.

Institutional Trading of Innospec

Large investors have recently made changes to their positions in the business. Blue Trust Inc. increased its stake in Innospec by 503.9% during the third quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company’s stock worth $96,000 after acquiring an additional 650 shares during the last quarter. Raymond James & Associates boosted its holdings in shares of Innospec by 10.0% in the 3rd quarter. Raymond James & Associates now owns 83,843 shares of the specialty chemicals company’s stock worth $9,482,000 after purchasing an additional 7,616 shares during the period. New York State Teachers Retirement System increased its position in shares of Innospec by 2.6% during the 3rd quarter. New York State Teachers Retirement System now owns 14,781 shares of the specialty chemicals company’s stock valued at $1,672,000 after purchasing an additional 371 shares during the last quarter. US Bancorp DE raised its holdings in Innospec by 323.6% during the 3rd quarter. US Bancorp DE now owns 5,490 shares of the specialty chemicals company’s stock valued at $621,000 after buying an additional 4,194 shares during the period. Finally, Leeward Investments LLC MA lifted its position in Innospec by 22.4% in the third quarter. Leeward Investments LLC MA now owns 86,004 shares of the specialty chemicals company’s stock worth $9,726,000 after buying an additional 15,750 shares during the last quarter. 96.64% of the stock is currently owned by institutional investors.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.